标题/作者	年份
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues M Parola, M Pinzani Molecular aspects of medicine 65, 37-55	2019
Molecular and cellular mechanisms of liver fibrosis and its regression T Kisseleva, D Brenner Nature Reviews Gastroenterology & Hepatology 18 (3), 151-166	2021
Liver fibrosis: mechanistic concepts and therapeutic perspectives N Roehlen, E Crouchet, TF Baumert Cells 9 (4), 875	2020
TGF-β in hepatic stellate cell activation and liver fibrogenesis—updated 2019 B Dewidar, C Meyer, S Dooley, N Meindl-Beinker Cells 8 (11), 1419	2019
Mouse models of nonalcoholic steatohepatitis: toward optimization of their relevance to human nonalcoholic steatohepatitis G Farrell, JM Schattenberg, I Leclercq, MM Yeh, R Goldin, N Teoh, ... Hepatology 69 (5), 2241-2257	2019
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification S Chidambaranathan-Reghupaty, PB Fisher, D Sarkar Advances in cancer research 149, 1-61	2021
Encyclopedia of molecular pharmacology S Offermanns, W Rosenthal Springer International Publishing	2021
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer F Wu, J Yang, J Liu, Y Wang, J Mu, Q Zeng, S Deng, H Zhou Signal Transduction and Targeted Therapy 6 (1), 218	2021
The myofibroblast at a glance P Pakshir, N Noskovicova, M Lodyga, DO Son, R Schuster, A Goodwin, ... Journal of Cell Science 133 (13), jcs227900	2020
Mechanical regulation of myofibroblast phenoconversion and collagen contraction B Hinz, CA McCulloch, NM Coelho Experimental cell research 379 (1), 119-128	2019
Critical role of estrogen in the progression of chronic liver diseases D Ezhilarasan Hepatobiliary & Pancreatic Diseases International 19 (5), 429-434	2020
Collagen biology and non‐invasive biomarkers of liver fibrosis MA Karsdal, SJ Daniels, S Holm Nielsen, C Bager, DGK Rasmussen, ... Liver International 40 (4), 736-750	2020
Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer JM O’Rourke, VM Sagar, T Shah, S Shetty World journal of gastroenterology 24 (39), 4436	2018
Cellular mechanisms of liver fibrosis P Acharya, K Chouhan, S Weiskirchen, R Weiskirchen Frontiers in Pharmacology 12, 671640	2021
Improvements in histologic features and diagnosis associated with improvement in fibrosis in nonalcoholic steatohepatitis: results from the nonalcoholic steatohepatitis clinical research network treatment trials EM Brunt, DE Kleiner, LA Wilson, AJ Sanyal, BA Neuschwander‐Tetri, ... Hepatology 70 (2), 522-531	2019
Lysyl oxidase (LOX) family members: rationale and their potential as therapeutic targets for liver fibrosis W Chen, A Yang, J Jia, YV Popov, D Schuppan, H You Hepatology 72 (2), 729-741	2020
Targeting cancer associated fibroblasts in liver fibrosis and liver cancer using nanocarriers L Kaps, D Schuppan Cells 9 (9), 2027	2020
An update on the recent advances in antifibrotic therapy F Tacke, R Weiskirchen Expert Review of Gastroenterology & Hepatology 12 (11), 1143-1152	2018
Golgi apparatus-targeted chondroitin-modified nanomicelles suppress hepatic stellate cell activation for the management of liver fibrosis J Luo, P Zhang, T Zhao, M Jia, P Yin, W Li, ZR Zhang, Y Fu, T Gong ACS nano 13 (4), 3910-3923	2019
Towards extracellular matrix normalization for improved treatment of solid tumors HS Abyaneh, M Regenold, TD McKee, C Allen, MA Gauthier Theranostics 10 (4), 1960	2020

1 - 20

计算机程序会自动估算并确定日期和引用次数。